Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy
- Autores
- Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; Prieto, Jhon E.; Tapias, Monica; Idrovo, Victor; Davalos, Milagros B.; Cairo, Fernando; Barreyro, Fernando Javier; Paredes, Mario Sebastian; Hernandez, Nelia; Avendaño, Karla; Diaz Ferrer, Javier; Yang, Ju Dong; Carrera, Enrique; Garcia, Jairo A.; Mattos, Angelo Z.; Hirsch, Bruno S.; Gonçalves, Pablo T.; Carrilho, Flair J.; Roberts, Lewis R.
- Año de publicación
- 2017
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.
Fil: Debes, Jose D.. University of Minnesota; Estados Unidos
Fil: Chan, Aaron J.. University of Minnesota; Estados Unidos
Fil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; Argentina
Fil: Kikuchi, Luciana. Universidade de Sao Paulo; Brasil
Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; Colombia
Fil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia
Fil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; Argentina
Fil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina
Fil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; Argentina
Fil: Hernandez, Nelia. Universidad de la República; Uruguay
Fil: Avendaño, Karla. Universidad de la República; Uruguay
Fil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú
Fil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados Unidos
Fil: Carrera, Enrique. Hospital Eugenio Espejo; Ecuador
Fil: Garcia, Jairo A.. Fundación Valle del Lili; Colombia
Fil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; Brasil
Fil: Carrilho, Flair J.. Universidade de Sao Paulo; Brasil
Fil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados Unidos - Materia
-
Demographics
Hepatocellular Carcinoma
Risk Factors
South America - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/41491
Ver los metadatos del registro completo
id |
CONICETDig_fb4e78f9e36031b620c893435639302c |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/41491 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapyDebes, Jose D.Chan, Aaron J.Balderramo, DomingoKikuchi, LucianaGonzalez Ballerga, EstebanPrieto, Jhon E.Tapias, MonicaIdrovo, VictorDavalos, Milagros B.Cairo, FernandoBarreyro, Fernando JavierParedes, Mario SebastianHernandez, NeliaAvendaño, KarlaDiaz Ferrer, JavierYang, Ju DongCarrera, EnriqueGarcia, Jairo A.Mattos, Angelo Z.Hirsch, Bruno S.Gonçalves, Pablo T.Carrilho, Flair J.Roberts, Lewis R.DemographicsHepatocellular CarcinomaRisk FactorsSouth Americahttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients.Fil: Debes, Jose D.. University of Minnesota; Estados UnidosFil: Chan, Aaron J.. University of Minnesota; Estados UnidosFil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; ArgentinaFil: Kikuchi, Luciana. Universidade de Sao Paulo; BrasilFil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; ColombiaFil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; ColombiaFil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; ColombiaFil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; ArgentinaFil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; ArgentinaFil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; ArgentinaFil: Hernandez, Nelia. Universidad de la República; UruguayFil: Avendaño, Karla. Universidad de la República; UruguayFil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; PerúFil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados UnidosFil: Carrera, Enrique. Hospital Eugenio Espejo; EcuadorFil: Garcia, Jairo A.. Fundación Valle del Lili; ColombiaFil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; BrasilFil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; BrasilFil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; BrasilFil: Carrilho, Flair J.. Universidade de Sao Paulo; BrasilFil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados UnidosWiley Blackwell Publishing, Inc2017-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/41491Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-1431478-3223CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1111/liv.13502info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13502info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:46:20Zoai:ri.conicet.gov.ar:11336/41491instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:46:20.261CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
title |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
spellingShingle |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy Debes, Jose D. Demographics Hepatocellular Carcinoma Risk Factors South America |
title_short |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
title_full |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
title_fullStr |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
title_full_unstemmed |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
title_sort |
Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy |
dc.creator.none.fl_str_mv |
Debes, Jose D. Chan, Aaron J. Balderramo, Domingo Kikuchi, Luciana Gonzalez Ballerga, Esteban Prieto, Jhon E. Tapias, Monica Idrovo, Victor Davalos, Milagros B. Cairo, Fernando Barreyro, Fernando Javier Paredes, Mario Sebastian Hernandez, Nelia Avendaño, Karla Diaz Ferrer, Javier Yang, Ju Dong Carrera, Enrique Garcia, Jairo A. Mattos, Angelo Z. Hirsch, Bruno S. Gonçalves, Pablo T. Carrilho, Flair J. Roberts, Lewis R. |
author |
Debes, Jose D. |
author_facet |
Debes, Jose D. Chan, Aaron J. Balderramo, Domingo Kikuchi, Luciana Gonzalez Ballerga, Esteban Prieto, Jhon E. Tapias, Monica Idrovo, Victor Davalos, Milagros B. Cairo, Fernando Barreyro, Fernando Javier Paredes, Mario Sebastian Hernandez, Nelia Avendaño, Karla Diaz Ferrer, Javier Yang, Ju Dong Carrera, Enrique Garcia, Jairo A. Mattos, Angelo Z. Hirsch, Bruno S. Gonçalves, Pablo T. Carrilho, Flair J. Roberts, Lewis R. |
author_role |
author |
author2 |
Chan, Aaron J. Balderramo, Domingo Kikuchi, Luciana Gonzalez Ballerga, Esteban Prieto, Jhon E. Tapias, Monica Idrovo, Victor Davalos, Milagros B. Cairo, Fernando Barreyro, Fernando Javier Paredes, Mario Sebastian Hernandez, Nelia Avendaño, Karla Diaz Ferrer, Javier Yang, Ju Dong Carrera, Enrique Garcia, Jairo A. Mattos, Angelo Z. Hirsch, Bruno S. Gonçalves, Pablo T. Carrilho, Flair J. Roberts, Lewis R. |
author2_role |
author author author author author author author author author author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Demographics Hepatocellular Carcinoma Risk Factors South America |
topic |
Demographics Hepatocellular Carcinoma Risk Factors South America |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients. Fil: Debes, Jose D.. University of Minnesota; Estados Unidos Fil: Chan, Aaron J.. University of Minnesota; Estados Unidos Fil: Balderramo, Domingo. Instituto Universitario de Ciencias Biomédicas de Córdoba; Argentina Fil: Kikuchi, Luciana. Universidade de Sao Paulo; Brasil Fil: Gonzalez Ballerga, Esteban. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina Fil: Prieto, Jhon E.. Organización Sanitas; Colombia. Centro de Enfermedades Hepáticas y Digestivas; Colombia Fil: Tapias, Monica. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia Fil: Idrovo, Victor. Organización Sanitas; Colombia. Fundación Santa Fe de Bogotá. Hospital Universitario; Colombia Fil: Davalos, Milagros B.. Hospital Nacional Edgardo Rebagliati Martins; Perú Fil: Cairo, Fernando. Provincia de Buenos Aires. Ministerio de Salud. Hospital Alta Complejidad en Red El Cruce Dr. Néstor Carlos Kirchner Samic; Argentina Fil: Barreyro, Fernando Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Nordeste; Argentina Fil: Paredes, Mario Sebastian. Provincia de Formosa. Ministerio de Salud. Hospital de Alta Complejidad "Pte. Juan Domingo Perón"; Argentina Fil: Hernandez, Nelia. Universidad de la República; Uruguay Fil: Avendaño, Karla. Universidad de la República; Uruguay Fil: Diaz Ferrer, Javier. Hospital Nacional Edgardo Rebagliati Martins; Perú Fil: Yang, Ju Dong. Mayo Clinic College of Medicine & Science; Estados Unidos Fil: Carrera, Enrique. Hospital Eugenio Espejo; Ecuador Fil: Garcia, Jairo A.. Fundación Valle del Lili; Colombia Fil: Mattos, Angelo Z.. Hospital Nossa Senhora da Conceição; Brasil Fil: Hirsch, Bruno S.. Hospital Nossa Senhora da Conceição; Brasil Fil: Gonçalves, Pablo T.. Hospital Nossa Senhora da Conceição; Brasil Fil: Carrilho, Flair J.. Universidade de Sao Paulo; Brasil Fil: Roberts, Lewis R.. Mayo Clinic College of Medicine & Science; Estados Unidos |
description |
Background & Aims: Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide. Most studies addressing the epidemiology of HCC originate from developed countries. This study reports the preliminary findings of a multinational approach to characterize HCC in South America. Methods: We evaluated 1336 HCC patients seen at 14 centres in six South American countries using a retrospective study design with participating centres completing a template chart of patient characteristics. The diagnosis of HCC was made radiographically or histologically for all cases according to institutional standards. Methodology of surveillance for each centre was following AASLD or EASL recommendations. Results: Sixty-eight percent of individuals were male with a median age of 64 years at time of diagnosis. The most common risk factor for HCC was hepatitis C infection (HCV, 48%), followed by alcoholic cirrhosis (22%), Hepatitis B infection (HBV, 14%) and NAFLD (9%). We found that among individuals with HBV-related HCC, 38% were diagnosed before age 50. The most commonly provided therapy was transarterial chemoembolization (35% of HCCs) with few individuals being considered for liver transplant (<20%). Only 47% of HCCs were diagnosed during surveillance, and there was no difference in age of diagnosis between those diagnosed incidentally vs by surveillance. Nonetheless, being diagnosed during surveillance was associated with improved overall survival (P = .01). Conclusions: Our study represents the largest cohort to date reporting characteristics and outcomes of HCC across South America. We found an important number of HCCs diagnosed outside of surveillance programmes, with associated increased mortality in those patients. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/41491 Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-143 1478-3223 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/41491 |
identifier_str_mv |
Debes, Jose D.; Chan, Aaron J.; Balderramo, Domingo; Kikuchi, Luciana; Gonzalez Ballerga, Esteban; et al.; Hepatocellular carcinoma in South America: Evaluation of risk factors, demographics and therapy; Wiley Blackwell Publishing, Inc; Liver International; 38; 1; 6-2017; 136-143 1478-3223 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1111/liv.13502 info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1111/liv.13502 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
publisher.none.fl_str_mv |
Wiley Blackwell Publishing, Inc |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842268786949881856 |
score |
13.13397 |